semaglutide aion Use of and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study - Simonsen - 2025 - Diabetes, Obesity and Metabolism Semaglutide may be associated with

GLP-1s Make Weight Loss Easier And More Attainable Now

It regulates the secretion and sensitivity of insulin while suppressing glucagon secretion and decreasing postprandial glucose levels

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these medications, a new sur | As the use of GLP-1 weight loss medications continues to grow, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these drugs, a new survey found.

Cazzola 2024)

Heres what you need to know about these popular medications.